MSP RECOVERY INC (LIFW)

US5537452097 - Common Stock

3.24  +1.65 (+103.77%)

After market: 2.73 -0.51 (-15.74%)

Fundamental Rating

1

LIFW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of LIFW have multiple concerns. LIFW has a valuation in line with the averages, but it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

LIFW had negative earnings in the past year.
In the past year LIFW has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of LIFW (-3.49%) is comparable to the rest of the industry.
LIFW has a worse Return On Equity (-32.40%) than 66.06% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LIFW has a better Gross Margin (66.22%) than 88.99% of its industry peers.
In the last couple of years the Gross Margin of LIFW has declined.
LIFW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

LIFW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LIFW has less shares outstanding
LIFW has a worse debt/assets ratio than last year.

2.2 Solvency

LIFW has an Altman-Z score of -1.22. This is a bad value and indicates that LIFW is not financially healthy and even has some risk of bankruptcy.
LIFW has a worse Altman-Z score (-1.22) than 81.65% of its industry peers.
LIFW has a Debt/Equity ratio of 2.54. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.54, LIFW is doing worse than 77.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC4.13%

2.3 Liquidity

A Current Ratio of 0.01 indicates that LIFW may have some problems paying its short term obligations.
With a Current ratio value of 0.01, LIFW is not doing good in the industry: 97.25% of the companies in the same industry are doing better.
LIFW has a Quick Ratio of 0.01. This is a bad value and indicates that LIFW is not financially healthy enough and could expect problems in meeting its short term obligations.
LIFW's Quick ratio of 0.01 is on the low side compared to the rest of the industry. LIFW is outperformed by 97.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01

1

3. Growth

3.1 Past

LIFW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1533.49%.
The Revenue has grown by 24.67% in the past year. This is a very strong growth!
LIFW shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -17.83% yearly.
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LIFW. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 0.10, the valuation of LIFW can be described as very cheap.
LIFW's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIFW is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, LIFW is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.1

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LIFW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MSP RECOVERY INC

NASDAQ:LIFW (12/6/2024, 8:00:02 PM)

After market: 2.73 -0.51 (-15.74%)

3.24

+1.65 (+103.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.25M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.1
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 66.22%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y264.17%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y